2 results
Approved WMOPending
To study the impact on intra-arterial ATP infusion on Annexin A5 targeting.
Approved WMOCompleted
Primary Objective• To compare the anti-tumor efficacy of oral single-agent rociletinib, as measured by investigator assessment of the progression-free survival (PFS), with that of single-agent cytotoxic chemotherapy in patients with EGFR mutated,…